Drupal.behaviors.print = function(context) {window.print();window.close();}>
Aria Diagnostics Raises $52.7M to Commercialize Non-Invasive Trisomy Test
January 09, 2012
Aria Diagnostics Raises $52.7M to Commercialize Non-Invasive Trisomy Test
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Verinata Health Sues Sequenom Over Prenatal Diagnostic Patent Rights
February 29, 2012 / Clinical Sequencing News
Aria Kicks off Clinical Trial for Non-Invasive Down Syndrome Test
January 12, 2012 / GenomeWeb Daily News
Natera Sues Sequenom over Noninvasive Prenatal Diagnosis IP
January 11, 2012 / GenomeWeb Daily News
In Suit, Aria Says Sequenom 'Misrepresents' Scope of Patent for Noninvasive Prenatal Testing
December 21, 2011 / Clinical Sequencing News
Sequenom Collects 18K Samples for MaterniT21 Plus in Q3, Expects to Bill for Over 50K Tests in 2012
November 14, 2012 / Clinical Sequencing News